Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder
CONCLUSIONS: Further research should explore how to integrate employment support into OUD treatment to improve patient outcomes, particularly among women.SCIENTIFIC SIGNIFICANCE: The current study addressed gaps in the literature by examining sex differences in MOUD initiation and diverse treatment outcomes in a large, national sample.PMID:37583120 | DOI:10.1111/ajad.13463 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - August 16, 2023 Category: Addiction Authors: Margaret Paschen-Wolff Shelly F Greenfield R Kathryn McHugh Kathleen Burlew Martina Pavlicova Tse-Hwei Choo Celestina Barbosa-Leiker Lesia M Ruglass Sarah Mennenga John Rotrosen Edward V Nunes Aimee N C Campbell Source Type: research
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder
CONCLUSIONS: Further research should explore how to integrate employment support into OUD treatment to improve patient outcomes, particularly among women.SCIENTIFIC SIGNIFICANCE: The current study addressed gaps in the literature by examining sex differences in MOUD initiation and diverse treatment outcomes in a large, national sample.PMID:37583120 | DOI:10.1111/ajad.13463 (Source: American Journal on Addictions)
Source: American Journal on Addictions - August 16, 2023 Category: Addiction Authors: Margaret Paschen-Wolff Shelly F Greenfield R Kathryn McHugh Kathleen Burlew Martina Pavlicova Tse-Hwei Choo Celestina Barbosa-Leiker Lesia M Ruglass Sarah Mennenga John Rotrosen Edward V Nunes Aimee N C Campbell Source Type: research
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder
CONCLUSIONS: Further research should explore how to integrate employment support into OUD treatment to improve patient outcomes, particularly among women.SCIENTIFIC SIGNIFICANCE: The current study addressed gaps in the literature by examining sex differences in MOUD initiation and diverse treatment outcomes in a large, national sample.PMID:37583120 | DOI:10.1111/ajad.13463 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - August 16, 2023 Category: Addiction Authors: Margaret Paschen-Wolff Shelly F Greenfield R Kathryn McHugh Kathleen Burlew Martina Pavlicova Tse-Hwei Choo Celestina Barbosa-Leiker Lesia M Ruglass Sarah Mennenga John Rotrosen Edward V Nunes Aimee N C Campbell Source Type: research
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder
CONCLUSIONS: Further research should explore how to integrate employment support into OUD treatment to improve patient outcomes, particularly among women.SCIENTIFIC SIGNIFICANCE: The current study addressed gaps in the literature by examining sex differences in MOUD initiation and diverse treatment outcomes in a large, national sample.PMID:37583120 | DOI:10.1111/ajad.13463 (Source: American Journal on Addictions)
Source: American Journal on Addictions - August 16, 2023 Category: Addiction Authors: Margaret Paschen-Wolff Shelly F Greenfield R Kathryn McHugh Kathleen Burlew Martina Pavlicova Tse-Hwei Choo Celestina Barbosa-Leiker Lesia M Ruglass Sarah Mennenga John Rotrosen Edward V Nunes Aimee N C Campbell Source Type: research
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder
CONCLUSIONS: Further research should explore how to integrate employment support into OUD treatment to improve patient outcomes, particularly among women.SCIENTIFIC SIGNIFICANCE: The current study addressed gaps in the literature by examining sex differences in MOUD initiation and diverse treatment outcomes in a large, national sample.PMID:37583120 | DOI:10.1111/ajad.13463 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - August 16, 2023 Category: Addiction Authors: Margaret Paschen-Wolff Shelly F Greenfield R Kathryn McHugh Kathleen Burlew Martina Pavlicova Tse-Hwei Choo Celestina Barbosa-Leiker Lesia M Ruglass Sarah Mennenga John Rotrosen Edward V Nunes Aimee N C Campbell Source Type: research
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder
CONCLUSIONS: Further research should explore how to integrate employment support into OUD treatment to improve patient outcomes, particularly among women.SCIENTIFIC SIGNIFICANCE: The current study addressed gaps in the literature by examining sex differences in MOUD initiation and diverse treatment outcomes in a large, national sample.PMID:37583120 | DOI:10.1111/ajad.13463 (Source: American Journal on Addictions)
Source: American Journal on Addictions - August 16, 2023 Category: Addiction Authors: Margaret Paschen-Wolff Shelly F Greenfield R Kathryn McHugh Kathleen Burlew Martina Pavlicova Tse-Hwei Choo Celestina Barbosa-Leiker Lesia M Ruglass Sarah Mennenga John Rotrosen Edward V Nunes Aimee N C Campbell Source Type: research
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder
CONCLUSIONS: Further research should explore how to integrate employment support into OUD treatment to improve patient outcomes, particularly among women.SCIENTIFIC SIGNIFICANCE: The current study addressed gaps in the literature by examining sex differences in MOUD initiation and diverse treatment outcomes in a large, national sample.PMID:37583120 | DOI:10.1111/ajad.13463 (Source: The American Journal on Addictions)
Source: The American Journal on Addictions - August 16, 2023 Category: Addiction Authors: Margaret Paschen-Wolff Shelly F Greenfield R Kathryn McHugh Kathleen Burlew Martina Pavlicova Tse-Hwei Choo Celestina Barbosa-Leiker Lesia M Ruglass Sarah Mennenga John Rotrosen Edward V Nunes Aimee N C Campbell Source Type: research
Dental Disorders Reported to the FDA Adverse Event Reporting System in Association with Buprenorphine: An Analysis by Ingredient Composition and Route of Administration
CONCLUSION: Subject to the limitations of spontaneous adverse event data, this study identified significantly disproportionate reporting of dental disorders to FAERS among patients treated with buprenorphine-containing medications, including formulations administered by sublingual, buccal and oral routes. These findings are consistent with prior data and suggest that regular oral care and proper dental hygiene be emphasized for patients undergoing therapy with orally dissolving buprenorphine.PMID:37526182 | DOI:10.2174/1574886318666230731151447 (Source: Current Drug Safety)
Source: Current Drug Safety - August 1, 2023 Category: Drugs & Pharmacology Authors: Richard H Woods Source Type: research
Dental Disorders Reported to the FDA Adverse Event Reporting System in Association with Buprenorphine: An Analysis by Ingredient Composition and Route of Administration
CONCLUSION: Subject to the limitations of spontaneous adverse event data, this study identified significantly disproportionate reporting of dental disorders to FAERS among patients treated with buprenorphine-containing medications, including formulations administered by sublingual, buccal and oral routes. These findings are consistent with prior data and suggest that regular oral care and proper dental hygiene be emphasized for patients undergoing therapy with orally dissolving buprenorphine.PMID:37526182 | DOI:10.2174/1574886318666230731151447 (Source: Current Drug Safety)
Source: Current Drug Safety - August 1, 2023 Category: Drugs & Pharmacology Authors: Richard H Woods Source Type: research
Buprenorphine/naloxone/paracetamol
(Source: Reactions Weekly)
Source: Reactions Weekly - August 1, 2023 Category: Drugs & Pharmacology Source Type: research
The toll of opioid dependence: A research report on the possible role of Toll-like receptor-4 and related immune markers in opioid dependence
CONCLUSION: The increase in TLR-4 after treatment with BNX may indicate the rescue from nonprescription opioid-induced immunosuppression or the introduction of a novel xenobiotics-associated molecular pattern of BNX.PMID:37485408 | PMC:PMC10358820 | DOI:10.4103/indianjpsychiatry.indianjpsychiatry_314_22 (Source: Indian Journal of Psychiatry)
Source: Indian Journal of Psychiatry - July 24, 2023 Category: Psychiatry Authors: Tathagata Mahintamani Debasish Basu Abhishek Ghosh Manni Luthra-Guptasarma Source Type: research
